{"SPADE_UN_17183": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17183", "Peptide Name": "TAMARA-peptide 1", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "GLKKLAELFHKLLKLG", "Sequence Length": 16, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "TAMRA, 5-(and-6)-carboxytetramethylrhodamine", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C87H150N22O19", "Mass": 1808.26, "PI": 10.0, "Net Charge": 4, "Hydrophobicity": 0.27, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Cell penetration and cell-selective drug delivery using Î±-helix peptides conjugated with gold nanoparticles.", "Pubmed ID": "23545289", "Reference": "Biomaterials. 2013 Jul;34(20)4872-9.", "Author": "Park H, Tsutsumi H, Mihara H.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=23545289"}], "Frequent Amino Acids": "LKG", "Absent Amino Acids": "CDIMNOPQRSTUVWY", "Basic Residues": 5, "Acidic Residues": 1, "Hydrophobic Residues": 8, "Polar Residues": 6, "Positive Residues": 5, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_01750", "Similarity": 1.0, "Sequence": "FLGSLIGAAIPAIKQLLGLKK"}, {"SPADE_ID": "SPADE_N_13158", "Similarity": 1.0, "Sequence": "KKLGWGLKK"}, {"SPADE_ID": "SPADE_N_13159", "Similarity": 1.0, "Sequence": "KKLGLWLGLKK"}]}}}